To determine the frequency of skin denervation in patients with SFN-related symptoms following Covid19 vaccination or infection.
A cross-sectional chart-review analysis of patients who were referred for a skin biopsy due to SFN-related symptoms during 2021. Patients were included if symptoms began within 1-60 days following Covid19 vaccination or infection.
We identified 22 patients, of which 17 (14 females, mean age 51, range 33-83) reported symptoms following vaccination. These occurred in 10 patients after the 1st, in 5 after the 2nd and in 2 after the 3rd dose, respectively. Symptoms following infection were reported by 5 patients (3 females, mean age 45, range 25-59). The mean time to symptoms onset following vaccination or infection was 9 and 27 days, respectively. All patients reported pain and sensory symptoms. Autonomic symptoms were reported by 8/17 (47%) following vaccination and by 3/5 patients (60%) following infection. Fatigue was reported by 11/17 patients (64%) following vaccination and by all patients following infection. Skin denervation was evident in 13/22 (59%) of patients; in 11/17 patients (64%) following vaccination and 2/5 patients (40%) following infection. Fisher’s exact test showed no correlation between skin denervation and autonomic symptoms (p=0.629) or fatigue (p=0.41).
This small cohort showed that skin denervation occurs in about half of the patients with SFN-related symptoms following Covid19 vaccination or infection.